STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Gabelli Healthcare & WellnessRx Trust SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Gabelli-affiliated entities filed an amended Schedule 13D reporting beneficial ownership of 3,514,000 Series G preferred shares of Gabelli Healthcare & WellnessRx Trust (GRX), representing 64.73% of the 5,428,514 shares outstanding as reported by the issuer.

The filing notes a recent transaction: the Gabelli Foundation purchased 200,000 Series G shares on October 28, 2025 at $10.0476 per share in a private placement, for approximately $2,009,520. Reported holdings include Associated Capital Group with 2,200,000 shares (40.53%), GAMCO Investors with 400,000 (7.37%), Mario J. Gabelli with 400,000 (7.37%), and the Gabelli Foundation with 514,000 (9.46%).

Positive
  • None.
Negative
  • None.

Insights

Amended 13D shows majority stake in GRX Series G preferred.

The filing consolidates beneficial ownership across Gabelli-affiliated entities at 64.73% of GRX’s Series G preferred, or 3,514,000 of 5,428,514 outstanding shares. A notable holder is Associated Capital Group with 2,200,000 shares (40.53%), indicating concentrated ownership within the group.

The document also records a fresh private placement purchase by the Gabelli Foundation of 200,000 shares at $10.0476 on October 28, 2025, totaling about $2,009,520. Voting and dispositive powers are described as sole for each reporting person, with fund-level proxy committees able to exercise voting power under certain circumstances.

Practical implications depend on ongoing communications with the issuer disclosed in the filing; any governance influence follows the rights of the Series G preferred and applicable rules. Subsequent filings may provide additional transaction details or changes in ownership.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


GAMCO INVESTORS, INC. ET AL
Signature:PETER D. GOLDSTEIN
Name/Title:GENERAL COUNSEL
Date:11/03/2025
GABELLI FOUNDATION, INC.
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:11/03/2025
GGCP, INC.
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:11/03/2025
Associated Capital Group, Inc.
Signature:PETER D. GOLDSTEIN
Name/Title:CHIEF LEGAL OFFICER
Date:11/03/2025
GABELLI MARIO J
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:11/03/2025

FAQ

What stake in GRX’s Series G preferred is reported in this 13D/A?

The reporting group disclosed 3,514,000 shares, equal to 64.73% of the 5,428,514 shares outstanding.

Which Gabelli-affiliated entity holds the largest GRX Series G position?

Associated Capital Group holds 2,200,000 shares, representing 40.53% of the Series G preferred.

Did the filing report a recent GRX preferred share purchase?

Yes. The Gabelli Foundation bought 200,000 Series G shares at $10.0476 on October 28, 2025 in a private placement (~$2,009,520).

How many GRX Series G preferred shares are outstanding?

The issuer reported 5,428,514 Series G preferred shares outstanding.

What are other notable reported holdings in GRX Series G?

GAMCO Investors 400,000 (7.37%), Mario J. Gabelli 400,000 (7.37%), and the Gabelli Foundation 514,000 (9.46%).

Why did the group file a long-form Schedule 13D?

They filed the long form to ensure communications with management align with Exchange Act reporting obligations.
Gabelli Health & Wellness

NYSE:GRX

GRX Rankings

GRX Latest News

GRX Latest SEC Filings

GRX Stock Data

143.66M
15.50M
1.83%
37.13%
0.02%
Asset Management
Financial Services
Link
United States
Rye